By adopting the JMAP method, the transition from diabetes to dialysis can be reduced to 1/5. Prevention is useful in areas where there is a shortage of specialists Takenori Sakai, Director of Internal Medicine, Municipal Yawatahama General Hospital.

https://medical-tribune.co.jp/news/2016/0902504563/

Suppression of dialysis transition from diabetic nephropathy has become an important social issue. A summer seminar of the Japan Society for the Prevention of Severity of Chronic Diseases (JMAP) was held in Tokyo on August 4th, which has been advocating the importance of this problem and has been practicing it in various places. (1) Extraction of high-risk cases using disease management MAP and ΔeGFR (2) Thorough patient guidance centered on salt reduction (3) Utilization of GLP-1 receptor agonists, which are expected to have a renal protective effect-JMAP method Introducing the announcement by Takenori Sakai of the Department of Internal Medicine, Municipal Yawatahama General Hospital (Ehime Prefecture), which introduced the latest outcomes of. ( Related article: Response to dialysis prevention with GLP-1 receptor agonists )

… If you are a member, log in here

Register Now

Doctor

Other medical personnel

If you register for Medical Tribune, you can see all the contents (free of charge), and doctors can also participate in the point program.

Related Tags

• #General internal medicine
• #Diabetes / endocrine diseases
• #Nephrology
• #Other domestic academic societies
• #Community medical care
• #Diabetes mellitus
• #Diabetes drug
• #Dialysis

Recommended articles for you

•  Responding to dialysis prevention with GLP-1 receptor agonist  2016.09.02
•  

The comment function is for doctor members only

Reading and writing comments is limited to doctor members.

Click here for new registration